Phenominer Database Results (4 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Experiment Notes Record ID Study ID
DA.PVG.1AV1-(D4Rat155-Spr) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 100.0 % in vivo visual assessment 0.0 0 69712 1162
DA.PVG.1AV1-(D4Rat155-Spr) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 14.3 d 0.3 1.12 in vivo visual assessment 0.0 0 69780 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 14 12.5 % 0.9 3.37 body weighing method 0.0 0 69800 1162
DA.PVG.1AV1-(D4Rat155-Spr) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 14 660.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69759 1162